000			01938 a2200529 4500
005			20250514005646.0
264		0	_c20011004
008			200110s 0 0 eng d
022			_a0027-8424
024	7		_a10.1073/pnas.151257998 _2doi
040			_aNLM _beng _cNLM
100	1		_aBiswas, D K
245	0	0	_aThe nuclear factor kappa B (NF-kappa B): a potential therapeutic target for estrogen receptor negative breast cancers. _h[electronic resource]
260			_bProceedings of the National Academy of Sciences of the United States of America _cAug 2001
300			_a10386-91 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aBase Sequence
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aCarbazoles _xpharmacology
650	0	4	_aCell Division _xdrug effects
650	0	4	_aCyclin D1 _xmetabolism
650	0	4	_aDNA Primers _xgenetics
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aI-kappa B Kinase
650	0	4	_aIndoles _xpharmacology
650	0	4	_aMammary Neoplasms, Experimental _xdrug therapy
650	0	4	_aMice
650	0	4	_aMice, Inbred A
650	0	4	_aMutation
650	0	4	_aNF-kappa B _xantagonists & inhibitors
650	0	4	_aProtein Kinase C _xantagonists & inhibitors
650	0	4	_aProtein Serine-Threonine Kinases _xgenetics
650	0	4	_aReceptors, Estrogen _xmetabolism
650	0	4	_aTetradecanoylphorbol Acetate _xpharmacology
650	0	4	_aTransfection
650	0	4	_aTumor Cells, Cultured
700	1		_aDai, S C
700	1		_aCruz, A
700	1		_aWeiser, B
700	1		_aGraner, E
700	1		_aPardee, A B
773	0		_tProceedings of the National Academy of Sciences of the United States of America _gvol. 98 _gno. 18 _gp. 10386-91
856	4	0	_uhttps://doi.org/10.1073/pnas.151257998 _zAvailable from publisher's website
999			_c11441737 _d11441737